Thermo Fisher Bioproduction Insights
-
Streamlining Data For Efficient Therapeutic Manufacturing
9/26/2025
An integrated solution for impurity and sterility analysis streamlines data, supports regulatory compliance, and uses built-in algorithms to deliver accurate, actionable results quickly.
-
Select The Best Analyte: A Guide To Effective Mycoplasma Testing
9/24/2025
As you build a Mycoplasma testing strategy to ensure drug safety, there are three analyte types to choose from: live Mycoplasma, RNA, and genomic DNA, each offering distinct advantages.
-
A Paradigm Shift From Glass Benchtop Bioreactors
8/14/2025
Learn how a bench-scale single-use bioreactor offers process development advantages over traditional glass systems, including higher efficiency, increased productivity, and enhanced sustainability.
-
5 Reasons To Reimagine Scalability With A Single-Use Bioreactor (S.U.B.)
8/14/2025
Unlock the power of single-use bioreactors with a scalable design that streamlines your process from development to production, while also supporting sustainability goals.
-
Scalability From 5L To 50L Using The DynaDrive Single-Use Bioreactor
8/14/2025
Maintaining a consistent bioprocess when scaling from 5 L to 50 L is achievable. This study shows how to successfully scale processes while maintaining cell density, viability, and protein production.
-
Enhance Your CHO-K1 GS Cell Culture Processes With A Next Generation Feed
7/21/2025
Boost your CHO-K1 GS cell culture with a two-part feed system that delivers chemically defined, animal origin-free formulations for consistency and compliance.
-
Scaling For Success: Preparing Your Cell Culture Workflow
7/21/2025
Uncover how early planning of medium, feed systems, and manufacturing workflow can mitigate costs, reduce delays, and accelerate therapeutic delivery to patients.
-
Consistent Improvement In CHO-K1 GS Performance With Efficient-Pro Feed 3 And Efficient-Pro Feed Enhancer
7/21/2025
Optimize your CHO-K1 GS cell line with advanced chemically defined, animal origin-free feeds. Achieve higher titers and reliable product quality.
-
Purification Of Complex mAb Modalities: Ask The Specialists
7/16/2025
Traditional mAb purification methods often fall short with complex modalities. Discover how experts tackle new impurities and structural complexities to enhance therapeutic antibody purification.
-
Aiming For Success In Early mAb Process Development And Beyond
7/15/2025
Developing a monoclonal antibody (mAb) requires strict quality compliance. Building on a strong foundation from the start with a quality by design (QbD) approach is key for success and minimizing variability.